Article
Patients with Colon Cancer Benefit from Using the Therapeutic Target lncRNA GAPLINC
2023-02-08
Abstract excerpt
<h4>Background: </h4> According to recent reports, some cancer subtypes have increased GAPLINC expression. The invasion and dissemination of cancer cells may be facilitated by GAPLINC expression. However, the therapeutic utility of GAPLINC in colon cancer (COAD) has not been studied. <h4>Materials: </h4> /Methods: We evaluated the mRNA expression of GAPLINC in COAD patients using data from the Cancer Genome Map t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a607d7aa-a76e-55ee-9148-b6180e0bdb05
- DOI
- 10.21203/rs.3.rs-2549650/v1
